News about 'treatment'

New WHO Guidelines On World AIDS day, the WHO Department of HIV/AIDS and the Stop TB Department issued new guidelines showing how people with HIV can be protected from tuberculosis with regular and low-cost preventive medication. This holds great promise for people living with HIV because TB is...

New TB/HIV Working Group Report: Priority Research Questions for TB&HIV in HIV-Prevalent and Resource-Limited Settings TB-HIV Report Nov 2010 In November 2008, the Global TB/HIV Working Group of the Stop TB Partnership , in collaboration with the WHO Stop TB and HIV/AIDS departments and the...

NC001 Today, the TB Alliance announced the first clinical trial to test multiple new TB drugs in combination; the trial is known as New Combination 1 (NC001).The experimental regimen undergoing testing in this trial consists of experimental TB drugs PA-824, Moxifloxacin, and Pyrazinamide, an...

Rebecca, a DOTS Worker with the Global Tuberculosis Institute at UMDNJ, talks about the types of patients she sees and about the possibility of contracting TB herself. Click here to view part one of this interview series.

Rebecca, a DOTS Worker with the Global Tuberculosis Institute at UMDNJ, talks about her experience working with patients at a local shelter.

In June of this year, the WGND interviewed a patient in New Jersey who was being treated by the DOTS program of the Global Tuberculosis Institute at UMDNJ. While his point-of-view is by no means universal, it provides an oft-overlooked window into tuberculosis in the United States. USA TB Patient...

Cameron Kaiser, MD Last week , Dr. Kaiser shared his thoughts and perspectives as a medical doctor on the current state of TB drug regimens. This week he shares specific ideas on how TB drug R&D could be improved. From a clinical perspective, I think there are some less obvious aims to optimize...

Cameron Kaiser, MD Viewpoint by Cameron Kaiser, MD, Medical Consultant for Tuberculosis, Riverside County Department of Public Health, California and guest WGND blogger. Antibiotics are, to the typical patient, always the quick fix. Despite our best attempts to convince them that their viral...

TB Misdiagnosis: Swedish Student Compelled to Take TB Drugs for a Year This is the first in our series “TB Treatment Stories,” where we meet people who have had first-hand experience taking standard tuberculosis drugs, which were developed and approved more than 40 years ago . As the Working Group...

This is part one of our interview, which was recorded on June 9, 2010 at the Global Tuberculosis Institute in Newark, NJ. Dr. Lee Reichman Lee B. Reichman, MD, MPH, is the Founding Executive Director of the New Jersey Medical School Global Tuberculosis Institute, and Professor of Medicine,...

(photo: http://www.musc.edu/chp/papem ) The route of drug delivery for TB drugs is an interesting one with the usual (and valuable) room for debate about different methods. While the standard mode of delivery for most drugs is oral, there is ongoing discussion as to whether aerosol delivery of TB...

Citizen News Service Vienna 2010: PREVENT TB: IPT works, IPT is safe Bobby Ramakant – Citizen News Service (CNS) ******************************************** In Lesotho, Isoniazid Preventive Therapy (IPT) to prevent latent TB infection from becoming active TB disease, is not available for ordinary...

Published by the WHO here: http://www.searo.who.int/en/Section10/Section2097/Section2106_10681.htm An online mini-series on TB and children is viewable here: http://stoptb.citizen-news.org/2010/07/online-discussion-mini-series-tb-and.html Over 250,000 children develop TB and 100,000 children will...

This article originally appeared in the American Journal of Nursing here: http://journals.lww.com/ajnonline/Fulltext/2010/07000/The_War_on_Tuberculosis.14.aspx Haile Meskel emerges from his Newark, New Jersey, row house and slips into the passenger seat of a shiny, late-model sedan, where a woman...

World Health Organization The World Health Organization’s Stop TB Department has published the fourth edition of Treatment of Tuberculosis: Guidelines. The guidelines contain a number of new recommendations, including a call to discontinue regimens based on just two months of rifampicin (2HRZE/6HE...